Patents Assigned to Hydra Biosciences, Inc.
  • Patent number: 7893260
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. Suitable compounds include but are not limited to, for example, substituted quinazolin-4-ones of formula I.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: February 22, 2011
    Assignee: Hydra Biosciences, Inc.
    Inventors: Jayhong A. Chong, Christopher Fanger, Glenn R. Larsen, William C. Lumma, Jr., Magdalene M. Moran, Amy Ripka, Dennis John Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20100273777
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: April 6, 2010
    Publication date: October 28, 2010
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong A. Chong, Christopher Fanger, Glenn R. Larsen, William C. Lumma, JR., Magdalene M. Moran, Amy Ripka, Dennis John Underwood, Manfred Weigele, Xiaoguang Zhen
  • Patent number: 7803790
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: September 28, 2010
    Assignee: Hydra Biosciences, Inc.
    Inventors: Jayhong A. Chong, Christopher Fanger, Glenn R. Larsen, William C. Lumma, Jr., Anu Mahadevan, Peter Meltzer, Magdalene M. Moran, Amy Ripka, Dennis John Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20100152209
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: November 3, 2006
    Publication date: June 17, 2010
    Applicant: Hydra Biosciences Inc.
    Inventors: Jayhong A. Chong, Christopher Fanger, Glenn R. Larsen, William C. Lumma, JR., Anu Mahadevan, Peter Meltzer, Magdalene M. Moran, Amy Ripka, Dennis John Underwood, Manfred Weigele, Xiaoguang Zhen
  • Patent number: 7671061
    Abstract: The present application relates to compounds and methods for treating pain, incontinence and other conditions.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: March 2, 2010
    Assignee: Hydra Biosciences, Inc.
    Inventors: Magdalene M. Moran, Christopher Fanger, Jayhong A. Chong, Colleen Mcnamara, Xiaoguang Zhen, Josh Mandel-Brehm
  • Publication number: 20090226929
    Abstract: The present invention provides methods and compositions related to a novel voltage sensitive protein comprising four transmembrane domains.
    Type: Application
    Filed: March 16, 2007
    Publication date: September 10, 2009
    Applicant: Hydra Biosciences, Inc
    Inventors: Magdalene M. Moran, Jayhong A. Chong
  • Publication number: 20090018147
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: May 12, 2008
    Publication date: January 15, 2009
    Applicant: Hydra Biosciences Inc.
    Inventors: Jayhong A. Chong, Christopher Fanger, Glenn R. Larsen, Magdalene M. Moran, Howard Ng, Amy Ripka, Dennis John Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20080311578
    Abstract: The present invention provides methods and compositions for expressing eukaryotic membrane proteins.
    Type: Application
    Filed: January 15, 2008
    Publication date: December 18, 2008
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong A. Chong, Magdalene M. Moran, David E. Clapham
  • Publication number: 20080146611
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: September 14, 2007
    Publication date: June 19, 2008
    Applicant: Hydra Biosciences Inc.
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Christopher Fanger, Amy Ripka, Glenn R. Larsen, Xiaoguang Zhen, Dennis John Underwood, Manfred Weigele
  • Publication number: 20070213321
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: November 15, 2006
    Publication date: September 13, 2007
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Christopher Fanger, Glenn Larsen, William Lumma, Magdalene Moran, Amy Ripka, Dennis Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20070179164
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: November 3, 2006
    Publication date: August 2, 2007
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Christopher Fanger, Glenn Larsen, William Lumma, Magdalene Moran, Amy Ripka, Dennis Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20070004785
    Abstract: The invention provides novel compositions and compounds that inhibit CatSper channel activity, that preferentially inhibits sperm hyperactivity over sperm motility, or both. The compounds of the invention are useful as contraceptive agents that may be adminstered to males, females, or concurrently to both sexual partners. The invention further provides methods of conducting drug discovery business and of conducting a reproductive medicine business. The invention also provides methods of identifying compounds that modulate sperm hypermotility.
    Type: Application
    Filed: June 15, 2006
    Publication date: January 4, 2007
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Magdalene Moran
  • Publication number: 20060270688
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: May 9, 2006
    Publication date: November 30, 2006
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Christopher Fanger, Glenn Larsen, William Lumma, Magdalene Moran, Amy Ripka, Dennis Underwood, Manfred Weigele, Xiaoguang Zhen